This animated video explores the results of the Cortese et al. 2018 study and provides an overview of the use, efficacy and safety data for Elvanse (lisdexamfetamine dimesylate) and the NICE recommendation.

Dr. Jeremy de Bono looks at the role of Intuniv ▼ (guanfacine) in clinical practice.

Dr. Helen Tindle reviews the place of amphetamines in the treatment pathway, aligned to the ADHD NICE guidelines 2018.

Dr. Sara Binder discusses how ADHD presents in females, considers treatment approaches during pregnancy and post-partum, and touches upon the hormonal impact of menopause upon cognition.

Dr. Sara Binder introduces one of her patient's journeys through marriage, motherhood and her career with ADHD.

Dr. Sara Binder and Dr. Joe Johnson discuss the considerations when managing female ADHD patients to ensure they are treated optimally.

In this video from the 15th annual Meeting of Minds conference, Prof. Gabriele Fischer shares insights into a comorbidity of ADHD: substance use disorder.

Dr. Chris Abbott shares his clinical experience supporting teenagers with ADHD and a substance use disorder to illustrate some of the key learnings from a 2023 consensus statement. 

Dr Peter Mason discusses the management of ADHD in people with substance use disorder, and summarises the conclusions of an expert consensus statement on this topic.